Channelchek

Noble Capital Markets Initiates Equity Research Coverage on Blackboxstocks Inc.

Retrieved on: 
Monday, March 7, 2022
Software, Social Media, Other Communications, Finance, Data Management, Communications, Professional Services, Technology, Intelligence, Social media, Research, Noble, View, Blackbox, Contract, News, Capital market, SEC, Company, Software as a service, CBOE, FINRA, Inc., New York Stock Exchange, NASDAQ, Security (finance), Blackboxstocks, Inc., Noble Capital Markets, Channelchek, Blackboxstocks, Inc., Noble Capital Markets, Channelchek, BLACKBOXSTOCKS, INC., NOBLE CAPITAL MARKETS, CHANNELCHEK

Blackboxstocks Inc. (NASDAQ: BLBX), a financial technology and social media hybrid platform offering real-time proprietary analytics for stock and options traders of all levels, is pleased to announce that Noble Capital Markets has initiated company-sponsored equity research coverage on the Company.

Key Points: 
  • Blackboxstocks Inc. (NASDAQ: BLBX), a financial technology and social media hybrid platform offering real-time proprietary analytics for stock and options traders of all levels, is pleased to announce that Noble Capital Markets has initiated company-sponsored equity research coverage on the Company.
  • The full report by Noble Capital Markets Senior Research Analyst Joe Gomes, as well as news and advanced market data on Blackboxstocks is available on Channelchek.
  • Noble Capital Markets, Inc. was incorporated in 1984 as a full-service SEC / FINRA registered broker-dealer, dedicated exclusively to serving underfollowed small / microcap companies through investment banking, wealth management, trading & execution, and equity research activities.
  • Research on Channelchek is provided by Noble Capital Markets, Inc., an SEC / FINRA registered broker-dealer since 1984. www.channelchek.com email: [email protected]
    View source version on businesswire.com: https://www.businesswire.com/news/home/20220307005323/en/

Virpax to Present at the NobleCon Online Pain Management Investor Forum on Channelchek.com on October 7, 2021

Retrieved on: 
Friday, October 1, 2021
Biotechnology, Pharmaceutical, Health, Clinical Trials, CNS, Nature, Securities Act of 1933, Chronic pain, CBD, Epilepsy, Noble, Research, Security (finance), Pain management, Central nervous system disease, Investor, NASDAQ, U.S. Securities and Exchange Commission, FDA, Cancer, Capital market, FREE, Ariad Pharmaceuticals, Inc. v. Eli Lilly & Co., Osteoarthritis, Private Securities Litigation Reform Act, Bupivacaine, Industry, Company, MET, Pain, FINRA, COVID-19, Post-traumatic stress disorder, Severe acute respiratory syndrome coronavirus 2, PTSD, Securities Exchange Act of 1934, SEC, Pharmaceutical industry, Risk management, Virpax Pharmaceuticals, Noble Capital Markets, Inc., Channelchek, VIRPAX PHARMACEUTICALS, NOBLE CAPITAL MARKETS, INC., CHANNELCHEK

The presentation can be accessed by registering (at no cost) for the Investor Forum at www.channelchek.com ; the investor portal created by Noble.

Key Points: 
  • The presentation can be accessed by registering (at no cost) for the Investor Forum at www.channelchek.com ; the investor portal created by Noble.
  • Additionally, a video webcast of the presentation will be available beginning October 7, 2021 on the Investors section of the Virpax Pharmaceuticals website at https://ir.virpaxpharma.com/ .
  • Virpax is developing branded, non-addictive pain management and neurological product candidates using its proprietary technologies to optimize and target drug delivery.
  • Envelta is an intranasal molecular-envelope enkephalin formulation being developed to manage acute and chronic pain, including pain associated with cancer.

ACCO Brands Corporation Announces Participation in Noble Capital Markets C-Suite Interview Series

Retrieved on: 
Tuesday, August 18, 2020
Professional services, Retail, Other Retail, Manufacturing, Finance, Other Manufacturing, Office Products, Financial markets, Finance, Money, ACCO Brands, ACCO, Financial Industry Regulatory Authority, New York Stock Exchange, Broker-dealer, ACCO Brands Corporation, Noble Capital Markets, Channelchek

ACCO Brands Corporation (NYSE: ACCO) today announced its participation in Noble Capital Markets C-Suite Interview Series, presented by Channelchek.

Key Points: 
  • ACCO Brands Corporation (NYSE: ACCO) today announced its participation in Noble Capital Markets C-Suite Interview Series, presented by Channelchek.
  • The interview was led by Noble Capital Markets Senior Analyst Joe Gomes.
  • ACCO Brands Corporation (NYSE: ACCO) is one of the world's largest designers, marketers and manufacturers of branded academic, consumer and business products.
  • Research on Channelchek is provided by Noble Capital Markets, Inc., an SEC / FINRA registered broker-dealer since 1984. www.channelchek.com email: [email protected]
    View source version on businesswire.com: https://www.businesswire.com/news/home/20200818005624/en/